GlassScriptPhysician profile
Susan G Latimer
NPI 1407943137
$859.77
in general payments reported to CMS, 2019-2025
8 companies · $290 in 2025
The $290 reported for 2025 was more than what 83% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $64.93 · 2021: $126 · 2023: $122 · 2024: $49.60 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.89 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $328.95 | 2019-2025 | Primescan Connect, Astra Tech Implant System, Fluorocore 2+ Dual Cure Core Build-Up Material + Fast Endodontic Post Cement |
| Zimvie INC. | $179.60 | 2025 | |
| Straumann USA LLC | $135.97 | 2019-2024 | |
| Align Technology, INC. | $85.50 | 2019-2023 | Invisalign |
| Zimmer Biomet Holdings, INC. | $64.93 | 2020 | |
| Geistlich Pharma, North America, INC. | $35.09 | 2019 | |
| Dentsply Ih INC. | $14.98 | 2019 | |
| Ultradent Products INC | $14.75 | 2025 | Opalescence |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Latimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.